Cargando…

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

BACKGROUND: Cumulative evidence from epidemiological, preclinical and clinical studies suggests estrogens may have psychoprotective effects in schizophrenic patients. Selective Estrogen Receptor Modulators could have therapeutic benefits in schizophrenia for both sexes without being hazardous to gyn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kianimehr, Gilda, Fatehi, Farzad, Hashempoor, Sara, Khodaei-Ardakani, Mohammad-Reza, Rezaei, Farzin, Nazari, Ali, Kashani, Ladan, Akhondzadeh, Shahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100751/ https://www.ncbi.nlm.nih.gov/pubmed/25012765 http://dx.doi.org/10.1186/2008-2231-22-55

Ejemplares similares

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Femicomfort in the Treatment of Premenstrual Syndromes: A Double-Blind, Randomized and Placebo Controlled Trial
por: Kashani, Ladan, et al.
Publicado: (2010)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

S53. COMPARISON OF RALOXIFENE AND ISRADIPINE AS AN ADJUNCTIVE TREATMENT IN COGNITIVE DEFICITS OF PATIENTS WITH SCHIZOPHRENIA
por: Vahdani, Bita, et al.
Publicado: (2018)

Effects of Antidepressant Medication on Brain-derived Neurotrophic Factor Concentration and Neuroplasticity in Depression: A Review of Preclinical and Clinical Studies
por: Esalatmanesh, Sophia, et al.
Publicado: (2023)

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
por: Rezaei, Farzin, et al.
Publicado: (2015)

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial
por: Akhondzadeh, Shahin, et al.
Publicado: (2003)

Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial
por: Kashani, Ladan, et al.
Publicado: (2022)

Personality Patterns in Narcotics Anonymous Members versus Individuals with Addiction Receiving Methadone Maintenance Therapy
por: Akhondzadeh, Shahin, et al.
Publicado: (2014)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer
por: Torrisi, R, et al.
Publicado: (2001)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
por: Lee, Dong-Yun, et al.
Publicado: (2022)

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2021)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
por: Brand, Bodyl A, et al.
Publicado: (2023)

Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial
por: Gong, Long, et al.
Publicado: (2020)

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene
por: da Silva, Benedito B, et al.
Publicado: (2007)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011)

A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes
por: Van Pelt, R.E., et al.
Publicado: (2013)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study
por: Bal, Uğur Abbas, et al.
Publicado: (2015)

Olfactory dysfunction in persian patients suffering from parkinson's disease
por: Soltanzadeh, Akbar, et al.
Publicado: (2011)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Microbiome and Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2019)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

Wernicke's Encephalopathy in a Young Girl Suffering from Acute Myeloblastic Leukemia
por: Ghorbani, Askar, et al.
Publicado: (2012)

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
por: Akhondzadeh, Shahin, et al.
Publicado: (2004)

Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
por: Lin, Tiao, et al.
Publicado: (2014)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eeg4qifbb5o28150m904lkjvst